PCM
PTX

Polaris Capital Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Polaris Capital Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5,698
Closed -$180K – 108
2015
Q3 		$180K Hold
5,698
– – 0.02% 102
2015
Q2 		$337K Hold
5,698
– – 0.04% 98
2015
Q1 		$609K Buy
+5,698
New +$543K 0.09% 88

Other funds holding PTX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Polaris Capital Management's PTX Position: Q4 2015 in Review

Polaris Capital Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2015, closing a stake of 5,698 shares — an estimated $180K sold.

Polaris Capital Management first reported a position in PTX in Q1 2015 and held it in 3 quarters. The position peaked at $609K in Q1 2015. 101 funds tracked by Wall St. Rank hold PTX as of Q4 2015.

  • Polaris Capital Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2015 after selling out during the quarter.
  • Polaris Capital Management sold 5,698 Pernix Therapeutics Holdings, Inc. shares in Q4 2015, an estimated $180K.
  • Polaris Capital Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q1 2015 and held it in 3 quarters.
  • Polaris Capital Management's Pernix Therapeutics Holdings, Inc. position peaked at $609K in Q1 2015.
  • 101 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2015.

Based on Polaris Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.